Manufacturer
DUOPHARMA MANUFACTURING (BANGI) SDN BHD
Contents
Mefenamic acid
Indication
Dental pain, Headache, Menorrhagia, Mild to moderate pain, Osteoarthritis, Pain and inflammation associated with musculoskeletal and joint disorders, Postoperative pain, Primary dysmenorrhoea, Rheumatoid arthritis
Instruction
Should be taken with food.
Drug interaction
May increase the risk of bleeding with other NSAIDs or salicylates (e.g. aspirin), anticoagulants (e.g. warfarin), corticosteroids, SSRI. Increased the risk of nephrotoxicity of ciclosporin or tacrolimus. May decrease efficacy of antihypertensive agents (e.g. ACE inhibitors, angiotensin II antagonists, ß-blockers). Decreased natriuretic effect of diuretics (e.g. furosemide, hydrochlorothiazide). Increased plasma levels and reduced renal clearance of lithium. Increased serum concentration of digoxin and methotrexate.
Malaysia
